BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 14482)

  • 21. [Evaluation of the effectiveness of and tolerance to a new psychopharmacological agent in the anxiety-depression syndrome (comparison in a double-blind study with diazepam)].
    Bertoletti P
    G Clin Med; 1977; 58(9-10):393-400. PubMed ID: 340314
    [No Abstract]   [Full Text] [Related]  

  • 22. [The "double-blind" procedure in study of the anxiolytic effects of the preparation Wy 3498 (Oxazepam). Evaluation of anxiety states with the Hamilton scale (H.S.)].
    Predescu V; Ciurezu T; Romila A; Pirée S; Ionescu G; Roman I; Braslă N; Florescu D; Damian N
    Neurol Psihiatr Neurochir; 1969; 14(2):153-65. PubMed ID: 5804686
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oxazepam in alcoholism, depression and anxiety neuroses. A preliminary trial].
    Malm U
    Nord Psykiatr Tidsskr; 1968; 22(2):174-81. PubMed ID: 5704634
    [No Abstract]   [Full Text] [Related]  

  • 24. Brief treatment with oxazepam in crisis intervention--with a symptom-profile study in acute anxiety patients.
    Dasberg HH; Shalif I
    Isr Ann Psychiatr Relat Discip; 1979 Sep; 17(3):201-8. PubMed ID: 295279
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of clinical findings on the use of a sympatholytic in cases of anxiety neuroses].
    Lima PR; de Miranda AP; Vieira CL
    Hospital (Rio J); 1968 Dec; 74(6):2091-7. PubMed ID: 5305626
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlled comparison of the therapeutic effects of natrium oxybutyrate and oxazepam.
    Vinar O; Dostalová J; Krsiak M; Reznícek V; Ivanys E
    Act Nerv Super (Praha); 1979 Oct; 21(3):156-8. PubMed ID: 517086
    [No Abstract]   [Full Text] [Related]  

  • 27. Self-reports of anxiety level and EEG changes after a single dose of benzodiazepines. Double-blind comparison of two forms of oxazepam.
    Ansseau M; Doumont A; Cerfontaine JL; Mantanus H; Rousseau JC; Timsit Berthier M
    Neuropsychobiology; 1984; 12(4):255-9. PubMed ID: 6398863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxepin or diazepam for anxious and anxious-depressed outpatients?
    Haskell DS; Gambill JD; Gardos G; McNair DM; Fisher S
    J Clin Psychiatry; 1978 Feb; 39(2):135-9. PubMed ID: 344303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 32. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comorbidity of anxiety-depression and its treatment].
    Guelfi JD
    Encephale; 1993 Jul; 19 Spec No 2():397-404. PubMed ID: 7904238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter controlled study of oxazepam in anxious elderly outpatients.
    Koepke HH; Gold RL; Linden ME; Lion JR; Rickels K
    Psychosomatics; 1982 Jun; 23(6):641-5. PubMed ID: 6750675
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Action of WY 3498 in hysteria and anxiety neuroses].
    Ballbe R; Jocano H
    Prensa Med Argent; 1970 Jul; 57(19):946-50. PubMed ID: 4935134
    [No Abstract]   [Full Text] [Related]  

  • 37. Controlled comparison of trebenzomine with doxepin as an antidepressant-anxiolytic.
    Pena-Ramos A; Muniz C; Goodman LI; Borgen LA
    J Clin Psychiatry; 1979 Feb; 40(2):104-6. PubMed ID: 368044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A technique in the evaluation of psychotropic medication based on a patient demand schedule: comparison of the efficacy of oxypertine, diazepam and placebo in anxiety.
    Bonn JA; Salkind MR; Rees WL
    Curr Ther Res Clin Exp; 1971 Sep; 13(9):561-7. PubMed ID: 5000457
    [No Abstract]   [Full Text] [Related]  

  • 39. [Oxazepam or WY 3498, a new muscle-relaxing tranquilizer in ambulatory treatment].
    Bobon J; Collard J; Breulet M
    Acta Neurol Psychiatr Belg; 1965 May; 65(5):327-34. PubMed ID: 4953877
    [No Abstract]   [Full Text] [Related]  

  • 40. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.